This page lists all pharmaceutical reports related to the field of Cardiovascular Disorders. The reports include market research reports and pipeline analyses.
Displaying 151 - 181 of 181 results
- Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth
- Pulmonary Arterial Hypertension clinical community builds order from chaos
- Anti-Obesity Treatments Report - Analysis & Forecasts 2009-2024
- Statins: The World Market, 2009-2024
- Stem Cells - World Analysis 2009-2024
- Companion Biomarkers in Drug Development
- Generic Benchmarking: Brand Erosion at Patent Expiry
- Therapeutic Monoclonal Antibodies Markets
- Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success
- New Approaches to Pharma Research and Development: Evolving strategies to rejuvenate Research and Development efficiency
- Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
- Accelerating Lead Generation: Emerging technologies and strategies
- Innovations in In-Vitro Diagnostics: New technologies, growth opportunities, and the future market outlook
- Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts
- Biosimilars Series: Forecast Analysis
- Global Cardiovascular Drugs Market 2009-2024
- Stroke: Treatments and Prescribing Practices - A Global Survey 2009
- Monoclonal Antibody Therapeutics 2009-2024
- World Generics Market 2009-2024
- The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets
- Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
- Hypertension: Treatments and Prescribing Practices - A Global Survey
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- India: Peripheral Arterial Disease, Thromboangiitis Obliterans and Critical Limb Ischemia - Epidemiology and Markets
- Forecast Insight: Dyslipidemia - While the market collapses, a well designed clinical trial program pays dividends for Crestor
- Commercial Insight: Antithrombotics - Crossroads at the patent cliff
- What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- Commercial Insight: Cardiovascular and metabolic market overview
- Forecast Insight: Antihypertensives New fixed dose combinations unable to stem the tide of patent expiries
- Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development